Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease
Living with chronic kidney disease can have drastic impacts on a patient and their family’s life. A patient and her caregiver share their story on managing it.
Empagliflozin shows consistent cardio-renal benefits in adults with heart failure with left ventricular ejection fraction over 40 percent regardless of chronic kidney disease status
Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease
Partnering in Cardiovascular, Renal and Metabolic Diseases
Our commitment to collaboration with science-driven partners and academia is driven by our ambition to help change the future for people living with cardiovascular, renal and metabolic diseases
Diseases that can be transmitted between animals and humans are more common than you may think – and they are on the rise. Find out how this affects you.
Heart disease and treatments can be similar in humans and animals. How?
Humans and animals are more alike than different. Having a heart disease can affect us similarly, and the way to prevent it can work for all as well. Watch and learn how